Results 101 to 110 of about 7,936 (162)

Treatment needs in mild-to-moderate chronic obstructive pulmonary disease: evidence from longitudinal studies. [PDF]

J Thorac Dis
Wang Z, Lin J, Cai G, Guan W, Wu F, Deng Z, Zhou Y, Zhong N, Ran P.   +8 more
europepmc   +1 more source

Response to Dr. Tsakok’s letter to the editor entitled “Comment on tiotropium” [PDF]

, 2010
Sylvia Adams, Antonio Anzueto, Dick D. Briggs, Inge Leimer, Steven Kesten   +4 more
openalex   +1 more source

Adiabatic-Bias Molecular Dynamics Simulations Reveal the Impact of Mutations on Muscarinic Antagonist Unbinding Kinetics. [PDF]

J Chem Inf Model
Coricello A, Chiaravalle AL, Musgaard M, Tehan BG, Elisi GM, Bottegoni G.   +5 more
europepmc   +1 more source

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD [PDF]

, 2011
Roland Buhl, Leonard Dunn, Carlos Disdier, Cheryl Lassen, Carolynn Amos, Michael V. Henley, Benjamin Krämer   +6 more
openalex   +1 more source

Comparable Clinical Outcomes with Tiotropium/Olodaterol or Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with COPD and Blood Eosinophil Count ≤300 Cells/μL. [PDF]

Int J Chron Obstruct Pulmon Dis
Sethi S, Clark B, Buysman EK, Sargent A, Bengtson LGS.   +4 more
europepmc   +1 more source

PRS5 BUDESONIDE/FORMOTEROL PLUS TIOTROPIUM (BUD/FORM + TIO) VS. SALMETEROL/FLUTICASONE PLUS TIOTROPIUM (SALM/FLU + TIO): A SYSTEMATIC REVIEW AND ADJUSTED INDIRECT COMPARISON BETWEEN TWO ALTERNATIVE TRIPLE TREATMENTS IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)

, 2010
SJ Edwards, Judith Gray
openalex   +1 more source

Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial [PDF]

, 2009
Donald P. Tashkin, Bartolomé R. Celli, Steven Kesten, Ted Lystig, Sunil Mehra, Marc Decramer   +5 more
openalex   +1 more source

Rational timing of combination therapy with tiotropium and formoterol in moderate and severe COPD [PDF]

, 2008
Claudio Terzano, Angelo Petroianni, Vittoria Conti, Daniela Ceccarelli, Elda Graziani, Alessandro Sanduzzi, Serena D'Avelli   +6 more
openalex   +1 more source

Quantitative Analysis of Muscarinic Antagonist Atropine and Tiotropium in Microvolume Plasma Using Liquid Chromatography-Mass Spectrometry: Application for Pharmacokinetic Studies. [PDF]

J Anal Methods Chem
Trancart M, Penot M, Meesemaecker G, Boffy R, Hanak AS, Calas AG, Taudon N.   +6 more
europepmc   +1 more source

The pharmacokinetics, pharmacodynamics and tolerability of PUR0200, a novel tiotropium formulation, in chronic obstructive pulmonary disease [PDF]

, 2018
Dave Singh, Arjun Ravi, Katie Kane, Tess Schmalbach, David L. Hava   +4 more
openalex   +1 more source